[HTML][HTML] Targeting CD33 for acute myeloid leukemia therapy
J Liu, J Tong, H Yang - BMC cancer, 2022 - Springer
Background The aim of this study was to analyze the level of CD33 expression in patients
with newly diagnosed AML and determine its correlation with clinical characteristics …
with newly diagnosed AML and determine its correlation with clinical characteristics …
[HTML][HTML] Targeting CD33 for acute myeloid leukemia therapy
J Liu, J Tong, H Yang - BMC Cancer, 2022 - bmccancer.biomedcentral.com
The aim of this study was to analyze the level of CD33 expression in patients with newly
diagnosed AML and determine its correlation with clinical characteristics. Samples were …
diagnosed AML and determine its correlation with clinical characteristics. Samples were …
Targeting CD33 for acute myeloid leukemia therapy.
J Liu, J Tong, H Yang - BMC Cancer, 2022 - go.gale.com
Background The aim of this study was to analyze the level of CD33 expression in patients
with newly diagnosed AML and determine its correlation with clinical characteristics …
with newly diagnosed AML and determine its correlation with clinical characteristics …
Targeting CD33 for acute myeloid leukemia therapy.
J Liu, J Tong, H Yang - BMC Cancer, 2022 - europepmc.org
Background The aim of this study was to analyze the level of CD33 expression in patients
with newly diagnosed AML and determine its correlation with clinical characteristics …
with newly diagnosed AML and determine its correlation with clinical characteristics …
[HTML][HTML] Targeting CD33 for acute myeloid leukemia therapy
J Liu, J Tong, H Yang - BMC Cancer, 2022 - ncbi.nlm.nih.gov
Background The aim of this study was to analyze the level of CD33 expression in patients
with newly diagnosed AML and determine its correlation with clinical characteristics …
with newly diagnosed AML and determine its correlation with clinical characteristics …
Targeting CD33 for acute myeloid leukemia therapy
J Liu, J Tong, H Yang - BMC cancer, 2022 - pubmed.ncbi.nlm.nih.gov
Background The aim of this study was to analyze the level of CD33 expression in patients
with newly diagnosed AML and determine its correlation with clinical characteristics …
with newly diagnosed AML and determine its correlation with clinical characteristics …
Targeting CD33 for acute myeloid leukemia therapy
J Liu, J Tong, H Yang - BMC Cancer, 2022 - search.proquest.com
Background The aim of this study was to analyze the level of CD33 expression in patients
with newly diagnosed AML and determine its correlation with clinical characteristics …
with newly diagnosed AML and determine its correlation with clinical characteristics …
[HTML][HTML] Targeting CD33 for acute myeloid leukemia therapy
J Liu, J Tong, H Yang - BMC Cancer, 2022 - bmccancer.biomedcentral.com
The aim of this study was to analyze the level of CD33 expression in patients with newly
diagnosed AML and determine its correlation with clinical characteristics. Samples were …
diagnosed AML and determine its correlation with clinical characteristics. Samples were …